EN
登录

雅培将在印度各地分销MSD的糖尿病药物Januvia、Janumet和Janumet XR

Abbott to Distribute MSD’s Diabetes Drugs Januvia, Janumet, and Janumet XR Across India

GeneOnline 等信源发布 2025-07-07 14:09

可切换为仅中文


by Mark Chiang

由马克·蒋

Share To

分享到

Abbott and MSD Pharmaceuticals have entered into an agreement to distribute oral anti-diabetic medications in India. Under the partnership, Abbott will handle the distribution of MSD’s diabetes management drugs, including Januvia, Janumet, and Janumet XR, across the country.

Abbott和MSD制药公司达成了一项在印度分销口服抗糖尿病药物的协议。根据该合作协议,Abbott将负责在全国范围内分销MSD的糖尿病管理药物,包括Januvia、Janumet和Janumet XR。

The collaboration aims to enhance access to these medications for individuals managing diabetes in India. Januvia (sitagliptin) is a widely used oral medication for type 2 diabetes that helps regulate blood sugar levels. Janumet and Janumet XR combine sitagliptin with metformin to provide additional glycemic control options.

此次合作旨在为印度管理糖尿病的患者增加获取这些药物的机会。Januvia(西他列汀)是一种广泛使用的2型糖尿病口服药物,有助于调节血糖水平。Janumet和Janumet XR将西他列汀与二甲双胍结合,提供了更多的血糖控制选择。

By leveraging Abbott’s distribution network, the partnership seeks to expand the availability of these treatments nationwide..

通过利用Abbott的分销网络,该合作伙伴关系旨在扩大这些治疗方案在全国范围内的可获得性。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源:GO-AI-ne1

Date: June 19, 2025

日期:2025年6月19日

Related posts:

相关文章:

Generic Drug Market Projected to Reach $1.4 Trillion by 2025, Boosting Healthcare Access in Emerging Markets

仿制药市场预计到2025年将达到1.4万亿美元,提升新兴市场医疗保健的可及性

FDA’s Novavax Vaccine Approval Delay Causes Uncertainty; Impacts Pfizer and Moderna

FDA对诺瓦瓦克斯疫苗的批准延迟引发不确定性,影响辉瑞和莫德纳

Sanofi to Present 18 Abstracts Highlighting Rilzabrutinib and Hemophilia Therapies at ISTH 2025

赛诺菲将在2025年ISTH会议上展示18篇摘要,重点介绍利扎布替尼和血友病疗法。

Safety, Sustainability, and Automation Highlighted as Key Priorities at INTERPHEX 2025 Conference

安全、可持续性和自动化被强调为INTERPHEX 2025会议的关键优先事项

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作:

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·江

Related Post

相关文章

News Flash

新闻快讯

Drug Channels Institute Reports Revised Illustration of Vertical Integration Trends in U.S. Healthcare

药品渠道研究所报告修订了美国医疗保健行业垂直整合趋势的图示

2025-07-07

2025年7月7日